LUCHETTI GENTILONI, Michele Maria
 Distribuzione geografica
Continente #
NA - Nord America 7.834
EU - Europa 3.463
AS - Asia 3.045
SA - Sud America 703
Continente sconosciuto - Info sul continente non disponibili 271
AF - Africa 206
OC - Oceania 8
Totale 15.530
Nazione #
US - Stati Uniti d'America 7.684
SG - Singapore 1.062
VN - Vietnam 620
IT - Italia 614
RU - Federazione Russa 587
CN - Cina 545
BR - Brasile 537
UA - Ucraina 456
SE - Svezia 383
DE - Germania 306
IE - Irlanda 273
HK - Hong Kong 230
FR - Francia 210
DK - Danimarca 163
TR - Turchia 163
GB - Regno Unito 159
FI - Finlandia 141
KR - Corea 90
CA - Canada 78
IN - India 78
CI - Costa d'Avorio 73
BD - Bangladesh 67
AR - Argentina 55
MA - Marocco 54
MX - Messico 40
PL - Polonia 37
IQ - Iraq 30
NL - Olanda 29
ZA - Sudafrica 29
JP - Giappone 28
CO - Colombia 27
EC - Ecuador 26
AT - Austria 23
BE - Belgio 19
ID - Indonesia 19
ES - Italia 17
VE - Venezuela 17
UZ - Uzbekistan 16
MY - Malesia 15
PY - Paraguay 15
SA - Arabia Saudita 14
TN - Tunisia 13
LT - Lituania 12
CL - Cile 11
KE - Kenya 11
PH - Filippine 10
OM - Oman 8
AU - Australia 7
EG - Egitto 7
IL - Israele 7
JM - Giamaica 6
PK - Pakistan 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
DZ - Algeria 5
NI - Nicaragua 5
TW - Taiwan 5
BY - Bielorussia 4
CG - Congo 4
EU - Europa 4
JO - Giordania 4
PE - Perù 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
KZ - Kazakistan 3
LB - Libano 3
NP - Nepal 3
PA - Panama 3
RS - Serbia 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
MD - Moldavia 2
PS - Palestinian Territory 2
SN - Senegal 2
BS - Bahamas 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
HT - Haiti 1
HU - Ungheria 1
KG - Kirghizistan 1
MT - Malta 1
MU - Mauritius 1
MW - Malawi 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SC - Seychelles 1
Totale 15.258
Città #
Ashburn 1.151
Chandler 714
Singapore 633
Jacksonville 474
Dallas 377
San Jose 316
Council Bluffs 309
Fairfield 306
Dublin 268
Boardman 263
Des Moines 263
Ho Chi Minh City 222
New York 219
Hong Kong 218
Wilmington 185
Beijing 151
The Dalles 147
Woodbridge 147
Hanoi 137
Ann Arbor 126
Seattle 123
Houston 119
Los Angeles 115
Lauterbourg 108
Moscow 108
Lawrence 107
Princeton 107
San Mateo 103
Centro 88
Cambridge 75
Abidjan 73
Milan 66
São Paulo 56
Hefei 54
San Diego 49
Munich 47
Orem 45
Helsinki 44
Phoenix 44
Buffalo 43
Redmond 42
Santa Clara 41
Turin 37
Da Nang 36
Brooklyn 33
Ancona 32
London 32
Warsaw 31
Atlanta 27
Denver 27
Chicago 25
Haiphong 25
Montreal 25
Rome 25
Chennai 23
Turku 23
Frankfurt am Main 22
Guangzhou 20
Rio de Janeiro 20
Toronto 19
Washington 19
Johannesburg 18
Norwalk 18
Tokyo 18
Wuhan 18
Boston 17
Brussels 17
Manchester 17
Pune 17
Marche 16
Porto 16
Shanghai 16
Stockholm 16
Miano 15
Amsterdam 14
Belo Horizonte 14
Mexico City 14
Hải Dương 13
Poplar 13
San Francisco 13
Tashkent 13
Columbus 11
Nuremberg 11
Vienna 11
Hangzhou 10
Quito 10
Brasília 9
Nairobi 9
Naples 9
Curitiba 8
Elk Grove Village 8
Goiânia 8
Guayaquil 8
Indianapolis 8
Istanbul 8
Mumbai 8
Porto Alegre 8
South Pasadena 8
Ankara 7
Baghdad 7
Totale 9.263
Nome #
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 326
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 198
ACCURACY OF DUAL-ENERGY COMPUTED TOMOGRAPHY FOR THE DETECTION OF BONE MARROW EDEMA IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS 196
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 194
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 190
Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma 188
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 184
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis 182
Successful treatment of a Caucasian case of multifocal Castleman¿s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report 177
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. 177
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 177
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 174
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 172
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 172
FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth 171
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 171
c-MYB transactivates the alpha 2(I) collagen gene. 168
Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile 165
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 161
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 158
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 158
A new HLA-DRB1*11 allele, DRB1*1144, identified by cloning and sequencing 156
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 155
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 155
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 154
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 153
A novel HLA-Cw*6 allele Cw*160102, identified by cloning and sequencing. 153
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 153
c-myb but not B-myb upregulates a1(I) and a2(I) collagen genes in fibroblasts 152
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 152
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 148
6. Tenoxicam and ketoprofen level monitoring with high-performance liquid chromatography in patients affected by rheumatoid arthritis 146
Certolizumab pegol for the treatment of psoriasis 146
c-myb proto-oncogene is expressed by quiescent fibroblasts and unlike B-myb gene does not correlate with proliferation 145
MR imaging of rheumatoid hand lesions: comparison with conventional radiology in 31 patients 145
Skin Involvement in SARS-CoV-2 Infection: Case Series 144
21. The Myb oncogene family of transcription factors: potent regulators of hematopoietic cells proliferation and differentiation. 142
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 141
5-methylcytosine content of DNA in blood and synovial mononuclear cells and in synovial tissue from patients affected by rheumatic autoimmune disease. 140
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 139
TOSSE STIZZOSA: PRESENTAZIONE ATIPICA DI UNA VASCULITE DEI GRANDI VASI 137
BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED ARTHRITIS: SAFETY PROFILE 136
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 136
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 134
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis 134
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 133
Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis. 133
Identification of a novel human DRB1*13 allele by sequence-based DRB typing. 132
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 132
Low number of complement C3B/C4B receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis 131
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 131
Dual-energy computed tomography for the detection of sacroiliac joints bone marrow oedema in patients with axial spondyloarthritis 131
The long pentraxin PTX3 is a marker of scleroderma fibroblasts activation 130
Stimulatory autoantibodies against PDGF receptors in Scleroderma 128
MULTICENTER VALIDATION OF THE DETECTION OF ARTHRITIS IN INFLAMMATORY BOWEL DISEASES (DETAIL) QUESTIONNAIRE FOR THE SCREENING OF SPONDYLOARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 128
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study 127
Reduction of bcl-2 in T-cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erithematosus 126
Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association 126
Dissociation between p93-B-myb and p75-c-myb expression during proliferation and differentiation of human myeloid cells lines 123
C-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation 123
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 122
c-myb, but not B-myb, upregulates alfa-1(I) and alfa-2(I) collagen gene expression in fibroblasts 122
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 122
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 121
Ha-Ras/ERK1-2 pathway is responsible for oxygen species generation in scleroderma fibroblasts 120
Patient reported outcomes and assessment of the quality of life in a cohort of patients affected by enteropathic spondyloarthritis: results of a monocentric prospective observational study at one year 118
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis 116
Effect of high-doses intravenous immunoglobulin in rheumatoid arthritis 116
Collagen loss and impaired wound healing is associated with c-Myb deficiency. 116
Stimulating autoantibodies to PDGF A/B receptor on sera from scleroderma patients 116
Biologics in inflammatory and immunomediated arthritis 116
SpA and PsA basic and translational research OP0205 Gut Dysbiosis in Patients with HLA-B27+ Ankylosing Spondylitis is Associated with Ileitis, Down-Regulation of Tight Junction Proteins, Increased Serum Levels of LPS and Monocytes Anergy 115
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. 112
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 112
Preliminary validation of the Simplified Psoriatic Arthritis Radiographic Score (SPARS) 112
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 111
Tissue-targeted antifibrotic gene therapy using a transgene driven by the promoter of the human type I collagen gene 111
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 111
Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study 109
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study 108
Stimulatory auto-antibodies to the PDGF receptor in patients with chronic GVHD. 108
H-Ras but not K-Ras is responsible for reactive oxygen species generation by scleroderma skin fibroblasts. 108
Oxidative stress in scleroderma - Maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway 107
Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: A review of the literature 104
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 104
Dolore Articolare Acuto 103
Characterization of a novel allele HLA-CW*160102 102
High risk low-grade lymphoma: Molecular remission after intensive sequential chemotherapy. 102
Vitamin d signaling in gastro-rheumatology: From immuno-modulation to potential clinical applications 102
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 102
Development of a Skin-Humanized Model as a Novel Tool to Investigate the Pathogenesis of Scleroderma 101
The treatment of UCD200 and scleroderma fibroblasts with siRNAs anti-C-MYB blocks type I collagen transcription: Toward a gene therapy of scleroderma 99
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 98
Therapeutic approach with IVIG in patients affected by connective tissue disease 98
Reply 98
HLA-B*4904, a new allele identified in two unrelated individuals from the same Italian region. 97
The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors 97
Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations 95
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 94
The important role of molecular analyses to evaluate the efficacy of Rituximab treatment in a patient affected by severe multineuropathy in mixed cryoglobulinemia disease. 93
Totale 13.607
Categoria #
all - tutte 67.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022594 0 0 0 47 13 56 30 49 50 70 107 172
2022/20231.956 164 216 140 187 137 439 3 101 403 14 114 38
2023/2024924 162 25 49 129 135 215 36 37 6 23 8 99
2024/20251.966 202 186 92 24 105 68 245 59 400 98 228 259
2025/20265.457 380 376 347 594 579 426 927 534 453 407 182 252
2026/20271.336 466 246 322 302 0 0 0 0 0 0 0 0
Totale 15.530